Patterson Cos Agrees to Be Acquired by Patient Square in $4.1B Deal

Dow Jones
2024-12-11
 

By Denny Jacob

 

Patterson Cos. agreed to be acquired by health-care investment firm Patient Square Capital in a deal valued around $4.1 billion.

The dental and animal health-care company said its shareholders will receive $31.35 a share in cash, a roughly 49% premium to its 30-calendar-day, volume-weighted average price ending Dec. 4, the last trading day before it announced an evaluation of strategic alternatives. The value of the deal includes the refinancing of Patterson's receivables facilities.

Patterson shares closed Tuesday at $23.11. The stock is down about 19% from the start of the year.

Patterson's board, excluding Chief Executive Don Zurbay--given his position as a management director--unanimously approved the transaction. It is expected to close in the fourth quarter of Patterson's fiscal 2025, at which time the company will go private.

The merger agreement includes a 40-day "go-shop" period that permits Patterson's board and its advisers to actively solicit alternative acquisition proposals.

Patient Square has about $11 billion in assets as of Sept. 30. Its portfolio includes companies such as Access TeleCare and Apollo Therapeutics, according to its website.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

December 11, 2024 07:24 ET (12:24 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10